Amantadine for chronic hepatitis C: Pilot study in 14 patients

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 12, 2000, Pages 1319-1322

  Andant, C ^a   Lamoril, J ^a   Deybach, J C ^a   Jouet, P ^a   Soule J C ^a  

^a HÔPITAL LOUIS MOURIER   (France)

Author keywords

Adverse events; Amantadine; Chronic hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; AMANTADINE; ANTIVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; ASTHENIA; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEPATITIS C; HUMAN; INSOMNIA; MALE; NEUTROPENIA; PILOT STUDY; PRIORITY JOURNAL; TREATMENT FAILURE; VISUAL DISORDER;

EID: 0034524860     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012120-00009     Document Type: Article

References (23)

1. Epidemiology of hepatitis C
2. Long term mortality after transfusion associated non-A, non-B hepatitis
3. Clinical outcomes after transfusion-associated hepatitis C
4. Natural history of liver fibrosis progression in patients with chronic hepatitis C
5. The treatment of chronic viral hepatitis
6. Therapy of chronic hepatitis C: Overview
7. A comparison of three interferon alpha-2b regimens for the long term treatment of chronic non-A, non-B hepatitis
8. Randomised trial of interferon alfa 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
9. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
10. Antiviral activity of amantadine: A review of laboratory and clinical data
11. Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man
12. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
13. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections
14. Prophylaxis and treatment of influenza
15. Amantadine in Parkinson's disease
16. Treatment of chronic hepatitis C with amantadine
17. The determination of the number of patients required in a preliminary and a follow up trial of a new chemotherapeutic agent
18. Amantadine hydrochloride decreases serum ALT activity without effects on serum HCV-RNA in chronic hepatitis C patients
19. Amantadine-HCl in the treatment of chronic hepatitis C in non-responders to alpha-interferon. Effect on ALT serum levels and viral load
20. A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy
21. Treatment of chronic hepatitis C with amantadine
22. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults
23. Adverse reactions to amantadine prophylaxis of influenza in a retirement home